TheJobsMapCeleCor Therapeutics jobs and careers
Del Mar, CA, United States
About CeleCor Therapeutics
CeleCor Therapeutics develops a RUC-4 novel small molecule inhibitor designed to be the first point of contact treatment for segment elevated myocardial infarction. The molecule inhibitor uses a thrombolytic agent for percutaneous coronary intervention that can be administered subcutaneously by auto-injector, enabling decreased mortality and laterdevelopment of heart failure.
Founded in 2017 by Andreas Ritzi, Barry Coller and Robert Hillman.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $18.8M
- Headquarters
- Del Mar
Leadership
The top of CeleCor Therapeutics's org chart, with how many people report into each leader.
Robert S. Hillman
Co-founder, President And CEO
5 reports
Marijo Gleeson
Chief Financial Officer
2 reports
Peter Finn
Corporate Counsel
Barry S. Coller
Chair, Medical & SAB, Co-Founder
Board
Chris Granger
Board Member
John Maraganore
Advisor
Sooin Kwon
Advisor
Andrew Weisenfeld
Advisor
Gilles Montalescot
Board Member
Jesse Dylan
Advisor
Jobs at CeleCor Therapeutics
No open positions right now. Explore more companies on TheJobsMap.